York University
Toronto, Ontario, M3J1P3, Canada
NCT Number: NCT06041087
This study investigates whether dairy products will positively impact loading exercise-induced bone turnover and bone cell activity and/or the post-exercise inflammatory response in healthy young adults compared to a carbohydrate drink and/or water.
Looking for future studies?
Notify Me18 year–30 year
All sexes
Interventional
Not applicable
Toronto, Ontario, M3J1P3, Canada
Introduction: Two million individuals at a cost of around 4.6 billion dollars a year in Canada suffer from osteoporosis. It is important to investigate strategies that can reduce bone loss and/or increase bone mass. Similarly, inflammation is associated with many different disease states, and investigating strategies to reduce systemic inflammation is prudent. Nutrition and exercise may be inexpensive and accessible strategies to improve bone health and inflammation and should be explored in different contexts and implemented. Our proposed research combines both nutrition and exercise along with the assessment of bone turnover and inflammatory markers in healthy young adults.
Design: Randomized controlled crossover trial
Participants: Healthy, university aged males and females.
Methods: During the study participants will complete 4 different acute exercise and nutritional supplement trials, in random order. The four trials are: 1) exercise+carbohydrate (CHO), 2) exercise+milk (Milk), 3) exercise+Greek yogurt (GY), and 4) exercise+water (W). The whole study will take a maximum of 16 weeks and each supplement trial will be separated by 2-4 weeks.
Outcomes: several markers of bone turnover and bone cell activity as well as markers of inflammation will be measured in the blood, before exercise and at different times post-exercise and post supplement consumption.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A single bout of high-intensity exercise (cycling intervals, resistance exercise, plyometrics) per trial.
50g consumed immediately after exercise and 1h after exercise.
Other names: CHO
500ml consumed immediately after exercise and 1h after exercise.
Other names: Milk
200g consumed immediately after exercise and 1h after exercise.
Other names: GY
500ml consumed immediately after exercise and 1h after exercise.
Other names: W
Time frame: Pre-exercise
OPG measured in serum/plasma
Time frame: Pre-exercise
RANKL measured in serum/plasma
Time frame: Pre-exercise
OC measured in serum/plasma
Time frame: Pre-exercise
SOST measured in serum/plasma
Time frame: Pre-exercise
CTX measured in serum/plasma
Time frame: 5 minutes post-exercise
OPG measured in serum/plasma
Time frame: 5 minutes post-exercise
RANKL measured in serum/plasma
Time frame: 5 minutes post-exercise
OC measured in serum/plasma
Time frame: 5 minutes post-exercise
SOST measured in serum/plasma
Time frame: 5 minutes post-exercise
CTX measured in serum/plasma
Time frame: 1 hour post-exercise
OPG measured in serum/plasma
Time frame: 1 hour post-exercise
RANKL measured in serum/plasma
Time frame: 1 hour post-exercise
OC measured in serum/plasma
Time frame: 1 hour post-exercise
SOST measured in serum/plasma
Time frame: 1 hour post-exercise
CTX measured in serum/plasma
Time frame: 4 hours post-exercise
OPG measured in serum/plasma
Time frame: 4 hours post-exercise
RANKL measured in serum/plasma
Time frame: 4 hours post-exercise
OC measured in serum/plasma
Time frame: 4 hours post-exercise
SOST measured in serum/plasma
Time frame: 4 hours post-exercise
CTX measured in serum/plasma
Time frame: 24 hours post-exercise
OPG measured in serum/plasma
Time frame: 24 hours post-exercise
RANKL measured in serum/plasma
Time frame: 24 hours post-exercise
OC measured in serum/plasma
Time frame: 24 hours post-exercise
SOST measured in serum/plasma
Time frame: 24 hours post-exercise
CTX measured in serum/plasma
Time frame: Pre-exercise
TNF-alpha measured in serum/plasma.
Time frame: Pre-exercise
IL-6 measured in serum/plasma.
Time frame: Pre-exercise
IL-1B measured in serum/plasma.
Time frame: Pre-exercise
IL-10 measured in serum/plasma.
Time frame: 5 minutes post-exercise
TNF-alpha measured in serum/plasma.
Time frame: 5 minutes post-exercise
IL-6 measured in serum/plasma.
Time frame: 5 minutes post-exercise
IL-1B measured in serum/plasma.
Time frame: 5 minutes post-exercise
IL-10 measured in serum/plasma.
Time frame: 1 hour post-exercise
TNF-alpha measured in serum/plasma.
Time frame: 1 hour post-exercise
IL-6 measured in serum/plasma.
Time frame: 1 hour post-exercise
IL-1B measured in serum/plasma.
Time frame: 1 hour post-exercise
IL-10 measured in serum/plasma.
Time frame: 4 hours post-exercise
TNF-alpha measured in serum/plasma.
Time frame: 4 hours post-exercise
IL-6 measured in serum/plasma.
Time frame: 4 hours post-exercise
IL-1B measured in serum/plasma.
Time frame: 4 hours post-exercise
IL-10 measured in serum/plasma.
Time frame: 24 hours post-exercise
TNF-alpha measured in serum/plasma.
Time frame: 24 hours post-exercise
IL-6 measured in serum/plasma.
Time frame: 24 hours post-exercise
IL-1B measured in serum/plasma.
Time frame: 24 hours post-exercise
IL-10 measured in serum/plasma.
Time frame: Pre-exercise
Leukocytes measured via flow cytometry
Time frame: 1 hour post-exercise
Leukocytes measured via flow cytometry
Time frame: 4 hours post-exercise
Leukocytes measured via flow cytometry
Time frame: 24 hours post-exercise
Leukocytes measured via flow cytometry
Time frame: Pre-exercise
Muscle soreness rated on a 0-5 scale.
Time frame: 5 minutes post-exercise
Muscle soreness rated on a 0-5 scale.
Time frame: 4 hours post-exercise
Muscle soreness rated on a 0-5 scale.
Time frame: 24 hours post-exercise
Muscle soreness rated on a 0-5 scale.
Time frame: Pre-exercise
Vertical jump height measured using a counter movement jump technique.
Time frame: 5 minutes post-exercise
Vertical jump height measured using a counter movement jump technique.
Time frame: 4 hours post-exercise
Vertical jump height measured using a counter movement jump technique.
Time frame: 24 hours post-exercise
Vertical jump height measured using a counter movement jump technique.
York University
Other
Dairy Supplementation and the Post-Exercise Bone and Inflammatory Response
Acronym: BIONEX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07008586
Behavior, Healthy
Cambridge, United Kingdom
View Trial DetailsNCT05439590
Glucose Metabolism Disorders, Healthy
Bozeman, Montana, United States
View Trial DetailsNCT04606628
Aging, Healthy
Oslo, Norway
View Trial DetailsNCT04786431
Autoimmune Diseases, Biomarker
View Trial Details